Hyam Levitsky Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hyam Levitsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hyam Levitsky. Hyam Levitsky is a Director in AGENUS INC ($AGEN) and a EVP, Research & CSO in Juno Therapeutics, Inc. ($JUNO) and a See Remarks in Juno Therapeutics, Inc. ($JUNO) and a Director in Replimune Group, Inc. ($REPL).
Address: C/O ANTIGENICS INC. 630 FIFTH AVENUE, SUITE 2100 NEW YORK 10111 NY
Companies in which Hyam Levitsky is an Insider
AGENUS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hyam Levitsky: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2007
$AGEN Market Capitalization: $345.02M
$AGEN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Juno Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hyam Levitsky: EVP, Research & CSO, See Remarks
Holdings: 131,334 shares
Current Value: $2,726,494
Latest Transaction: Feb 09 2017
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Replimune Group, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hyam Levitsky: Director
Holdings: 0 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Hyam Levitsky
Sentiment: All, AGEN, JUNO, REPL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
| Apr 02 2020 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 9.78 | 16,500 | 161,370 | 16,500 | |
| Apr 03 2019 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 15.50 | 13,500 | 209,250 | 13,500 | |
| Jul 26 2018 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 15.00 | 27,000 | 405,000 | 27,000 | |
| Feb 09 2017 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Option Exercise | A | 20.76 | 68,182 | 1,415,458 | 68,182 | |
| Feb 09 2017 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Grant | A | 0.00 | 14,634 | 0 | 131,334 | 116.7 K to 131.3 K (+12.54 %) |
| Jun 21 2016 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Sell | S | 43.20 | 300 | 12,960 | 116,700 | 117 K to 116.7 K (-0.26 %) |